These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9753710)

  • 121. Biomarkers of obesity and subsequent cardiovascular events.
    Musaad S; Haynes EN
    Epidemiol Rev; 2007; 29():98-114. PubMed ID: 17494057
    [TBL] [Abstract][Full Text] [Related]  

  • 122. PPARgamma in human and mouse physiology.
    Heikkinen S; Auwerx J; Argmann CA
    Biochim Biophys Acta; 2007 Aug; 1771(8):999-1013. PubMed ID: 17475546
    [TBL] [Abstract][Full Text] [Related]  

  • 123. 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies.
    Gurnell M
    PPAR Res; 2007; 2007():83593. PubMed ID: 17389771
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Genetic manipulations of PPARs: effects on obesity and metabolic disease.
    Barak Y; Kim S
    PPAR Res; 2007; 2007():12781. PubMed ID: 17389768
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation.
    Shimizu M; Yamashita D; Yamaguchi T; Hirose F; Osumi T
    Mol Cell Biochem; 2006 Jun; 286(1-2):33-42. PubMed ID: 16534556
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
    Francis GA; Li G; Casey R; Wang J; Cao H; Leff T; Hegele RA
    BMC Med Genet; 2006 Jan; 7():3. PubMed ID: 16412238
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scallissi N; Speranza AC; Gomes S; Hirata MH
    J Endocrinol Invest; 2005 Feb; 28(2):129-36. PubMed ID: 15887858
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Monogenic syndromes of abnormal glucose homeostasis: clinical review and relevance to the understanding of the pathology of insulin resistance and beta cell failure.
    Porter JR; Barrett TG
    J Med Genet; 2005 Dec; 42(12):893-902. PubMed ID: 15772126
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
    Sauder S; Kölsch H; Lütjohann D; Schulz A; von Bergmann K; Maier W; Heun R
    J Neural Transm (Vienna); 2005 Oct; 112(10):1381-9. PubMed ID: 15666037
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
    Tsai YS; Kim HJ; Takahashi N; Kim HS; Hagaman JR; Kim JK; Maeda N
    J Clin Invest; 2004 Jul; 114(2):240-9. PubMed ID: 15254591
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Candidate genes for type 2 diabetes.
    Parikh H; Groop L
    Rev Endocr Metab Disord; 2004 May; 5(2):151-76. PubMed ID: 15041791
    [No Abstract]   [Full Text] [Related]  

  • 132. Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm.
    Cock TA; Houten SM; Auwerx J
    EMBO Rep; 2004 Feb; 5(2):142-7. PubMed ID: 14755307
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
    Norris AW; Chen L; Fisher SJ; Szanto I; Ristow M; Jozsi AC; Hirshman MF; Rosen ED; Goodyear LJ; Gonzalez FJ; Spiegelman BM; Kahn CR
    J Clin Invest; 2003 Aug; 112(4):608-18. PubMed ID: 12925701
    [TBL] [Abstract][Full Text] [Related]  

  • 134. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.
    Celi FS; Shuldiner AR
    Curr Diab Rep; 2002 Apr; 2(2):179-85. PubMed ID: 12643137
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Genetics of insulin resistance.
    Mercado MM; McLenithan JC; Silver KD; Shuldiner AR
    Curr Diab Rep; 2002 Feb; 2(1):83-95. PubMed ID: 12643127
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Regulation of uncoupling protein-2 mRNA in L6 myotubules: I: Thiazolidinediones stimulate uncoupling protein-2 gene expression by a mechanism requiring ongoing protein synthesis and an active mitogen-activated protein kinase.
    López-Solache I; Marie V; Vignault E; Camirand A; Silva JE
    Endocrine; 2002 Nov; 19(2):197-208. PubMed ID: 12588051
    [TBL] [Abstract][Full Text] [Related]  

  • 137. acp Best Practice No 168. The investigation and management of obesity.
    Labib M
    J Clin Pathol; 2003 Jan; 56(1):17-25. PubMed ID: 12499427
    [TBL] [Abstract][Full Text] [Related]  

  • 138. SDP1 is a peroxisome-proliferator-activated receptor gamma 2 co-activator that binds through its SCAN domain.
    Babb R; Bowen BR
    Biochem J; 2003 Mar; 370(Pt 2):719-27. PubMed ID: 12444922
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.
    Smith MR; Kantoff PW
    Invest New Drugs; 2002 May; 20(2):195-200. PubMed ID: 12099579
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Obesity is associated with premature occurrence of acute myocardial infarction.
    Suwaidi JA; Wright RS; Grill JP; Hensrud DD; Murphy JG; Squires RW; Kopecky SL
    Clin Cardiol; 2001 Aug; 24(8):542-7. PubMed ID: 11501605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.